10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 327,379 | 334,820 | 222,379 | 234,459 | 274,695 |
| Marketable Securities | 65,506 | 85,970 | 210,238 | 218,435 | 225,546 |
| Receivables | 87,685 | 77,940 | 104,211 | 83,549 | 76,204 |
| Inventories | 83,687 | 82,307 | 81,629 | 78,629 | 70,646 |
| TOTAL | $582,940 | $601,894 | $635,035 | $629,422 | $666,232 |
| Non-Current Assets | |||||
| PPE Net | 284,913 | 292,106 | 289,328 | 257,694 | 223,001 |
| Intangibles | 26,801 | 27,459 | 27,369 | 28,004 | 28,639 |
| Other Non-Current Assets | 94,984 | 92,571 | 77,248 | 81,087 | 83,719 |
| TOTAL | $406,698 | $412,136 | $393,945 | $366,785 | $335,359 |
| Total Assets | $989,638 | $1,014,030 | $1,028,980 | $996,207 | $1,001,591 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,124 | 29,317 | 21,599 | 21,594 | 26,731 |
| Accrued Expenses | 56,460 | 64,960 | 92,454 | 90,203 | 76,727 |
| TOTAL | $98,087 | $112,006 | $130,957 | $126,855 | $117,908 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,217 | 8,530 | 7,867 | 6,665 | 6,473 |
| Other Non-Current Liabilities | 98,250 | 99,639 | 89,115 | 93,560 | 100,167 |
| TOTAL | $98,250 | $99,639 | $92,280 | $93,560 | $100,167 |
| Total Liabilities | $196,337 | $211,645 | $223,237 | $220,415 | $218,075 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,418 | 116,192 | 115,357 | 114,464 | 113,914 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,142,482 | -1,080,068 | -1,029,321 | -1,012,106 | -970,192 |
| Other shareholders' equity | -969 | -1,479 | -4,335 | -5,492 | -3,965 |
| TOTAL | $793,301 | $802,385 | $805,743 | $775,792 | $783,516 |
| Total Liabilities And Equity | $989,638 | $1,014,030 | $1,028,980 | $996,207 | $1,001,591 |